Top Story

Morbidity increased among childhood cancer survivors

April 1, 2015

The projected increase in the number of survivors of childhood cancer has corresponded with an increase in the morbidity burden of this population, according to study results.

A majority of childhood cancer survivors who survived 5 or more years since their diagnosis are estimated to have at least one chronic health condition, results showed.

Jeffrey Weber, MD In the Journals

Nivolumab demonstrates superiority to chemotherapy for advanced melanoma

March 31, 2015
Nivolumab was associated with a greater objective response rate and an improved toxicity profile compared with chemotherapy in patients with advanced melanoma who had…
Robert L. Coleman, MD Meeting News Coverage

Bevacizumab plus chemotherapy improves OS in recurrent ovarian cancer

March 31, 2015
The addition of bevacizumab to a standard chemotherapy regimen conferred a median 5-month survival improvement among women with ovarian cancer, according to results of a…
David Weinberg In the Journals

AGA guideline recommends change in diagnosis, management of asymptomatic pancreatic cysts

March 31, 2015
The American Gastroenterological Association has released a new guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts, which recommends…
FDA News

FDA strengthens warning, changes prescribing instructions for Feraheme

March 31, 2015
The FDA approved the addition of a boxed warning and updated the prescribing instructions for the anemia drug ferumoxytol, according to a press release from the…
More News Headlines »
Activity cover

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
Meeting News Coverage Video
thumbnail for video 4126759064001

Solid organ transplant recipients at higher risk for skin cancer

March 22, 2015
SAN FRANCISCO – In this video, Sarah Tuttleton Arron, MD, PhD, FAAD, discusses her research on mortality from…
More »
New Advances, New Options: Evaluating the Changing Landscape of Hemophilia

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »